It is unknown if mometasone furoate is excreted in breast milk but other corticosteroids are and therefore caution should be exercised when administering to nursing mothers. The benefits and risks of use should be considered in pregnant patients
In animal studies of pregnancy, some fetal toxic effects were seen at or above the maximum recommended human dose, though rodents are more sensitive to these effects than humans. Symptoms of chronic overuse may present as hypercorticism and adrenal suppression, and patients may not require any more treatment than monitoring. Overdose with a mometasone furoate inhaler may occur with chronic overuse. locasone also reduces inflammation by blocking transcription factors such as activator-protein-1 and nuclear factor kappa B (NF-kappaB). Once at the nucleus, receptors dimerize and bind to a DNA sequence known as the glucocorticoid response element which either increases expression of anti-inflammatory molecules or inhibits expression of pro-inflammatory molecules (such as interleukins 4 and 5). locasone binding to a glucocorticoid receptor causes conformational changes in the receptor, separation from chaperones, and the receptor moves to the nucleus. locasone has a particularly high receptor affinity compare to other corticosteroids, 22 times higher than that of dexamethasone. There is also evidence of inhibition of histamine, leukotrienes, and cytokines.Ĭorticosteroids diffuse across cell membranes into the cytosol of cells where they bind to glucocorticoid receptors to produce their activity. In asthma, mometasone is believed to inhibit mast cells, eosinophils, basophils, and lymphocytes.
#Metaz ointment skin
Locasone is also used to associated treatment for these conditions: Allergic Rhinitis (AR), Asthma, Dermatitis, Dermatitis, Eczematous caused by superficial Fungal skin infection, Moderate to Severe Plaque Psoriasis, Polyps, Nasal, Pruritus, Psoriasis, Psoriasis, Moderate to Severe, Seasonal Allergies, Skin Diseases, Eczematous, Skin Infections The ointment is indicated for symptomatic treatment of dermatitis and pruritis in patients ≥2 years. The nasal spray is indicated for treating nasal symptoms of allergic rhinitis in patients ≥2 years, treating symptoms of nasal congestion from seasonal allergic rhinitis in patients ≥2 years, treating nasal polyps in patients ≥18 years, and prophylaxis of seasonal allergic rhinitis in patients ≥12 years.
The inhaler is indicated for prophylaxis of asthma in patients ≥4 years. There are 3 formulations of mometasone furoate with various indications. Locasone is a corticosteroid used to treat asthma, allergic rhinitis, nasal congestion, nasal polyps, dermatitis, and pruritus. locasone diffuses across cell membranes to activate pathways responsible for reducing inflammation. locasone also has a lower affinity to mineralocorticoid receptors than natural corticosteroids, making it more selective in its action. Mometasone is a synthetic corticosteroid with an affinity for glucocorticoid receptors 22 times higher than that of dexamethasone. locasone is formulated as a dry powder inhaler, nasal spray, and ointment for its different indications. It has a glucocorticoid receptor binding affinity 22 times stronger than dexamethasone and higher than many other corticosteroids as well. Locasone is a corticosteroid drug that can be used for the treatment of asthma, rhinitis, and certain skin conditions.
0 kommentar(er)
